SynthesisOncotarget2015

FCGR2A, FCGR3A polymorphisms and therapeutic efficacy of anti-EGFR monoclonal antibody in metastatic colorectal cancer.

Hou-Qun Ying et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.